Results 331 to 340 of about 699,051 (382)

Combined Effect of Metals, PFAS, Phthalates, and Plasticizers on Cardiovascular Disease Risk. [PDF]

Toxics
Jehu-Appiah D, Obeng-Gyasi E.
europepmc   +1 more source

The impact of prepregnancy overweight and obesity on newborn glucose-lipid metabolism: An observational study. [PDF]

Medicine (Baltimore)
Chen X, Zhang J, Li H, Tang Y, Zhang Y, Ma Z, Hu Y.   +6 more
europepmc   +1 more source

Comparison of Visceral Adiposity and Plasma Atherogenicity Indices, Which are Cardiovascular Risk Markers in Hypothyroid Patients and Healthy Controls. [PDF]

Int J Gen Med
Pekgör S, Eryılmaz MA, Şentürk H.
europepmc   +1 more source

Genome-wide study links cardiometabolic factors to cognition via APOA4-APOA5-ZPR1-BUD13 and other loci in rural Indians. [PDF]

Alzheimers Dement
Chakraborty S, Subramanian K, Rajesh A, Majumder R, Rupanagudi KV, Mensegere A, TLSA study team, Issac TG, SANSCOG study team, Sundarakumar J, Kahali B.   +10 more
europepmc   +1 more source

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

J Clin Endocrinol Metab
Semmler G, Baumgartner C, Metz M, Gensluckner S, Habisch H, Hofer H, März W, Offner F, Völkerer A, Petrenko O, Wernly B, Draxler-Dworzak S, Neyer M, Nigmann C, Greber-Platzer S, Esterbauer H, Madl T, Aigner E, Scherer T, Datz C.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Triglycerides and cardiovascular disease

The Lancet, 2014
After the introduction of statins, clinical emphasis first focussed on LDL cholesterol-lowering, then on the potential for raising HDL cholesterol, with less focus on lowering triglycerides. However, the understanding from genetic studies and negative results from randomised trials that low HDL cholesterol might not cause cardiovascular disease as ...
B. Nordestgaard, A. Varbo
semanticscholar   +5 more sources